Better - Tirzepatide: Dual GIP/GLP-1 Receptor Agonist Tirzepatide (Mounjaro) takes it further by acting as a dual agonist of both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
A Mounjaro has effects that inhibit gastrointestinal activity, so while it suppresses appetite, gastrointestinal symptoms such as anorexia, nausea, and burping may occur
Youll feel supported every step of the way in a safe and welcoming environment, where your comfort and well-being always come first
Ueda P, Sderling J, Wintzell V, Svanstrm H, Pazzagli L, Eliasson B, et al
Can I use tap water to reconstitute glutathione
Researchers have found diseases including cardiovascular disease, non-alcoholic fatty liver disease, diabetic chronic kidney disease, osteoarthritis, autoimmune disease, alcohol use disorder and more could be positively impacted by GLP-1RA therapy